Losartan for treatment of epidermolysis bullosa: A new perspective

Dermatol Ther. 2021 Jan;34(1):e14638. doi: 10.1111/dth.14638. Epub 2020 Dec 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epidermolysis Bullosa Dystrophica*
  • Epidermolysis Bullosa* / diagnosis
  • Epidermolysis Bullosa* / drug therapy
  • Humans
  • Losartan

Substances

  • Losartan